pancreatitis from glp-1 GLP-1 Agonists Linked to Reduced

Combined stimulation of glucagon-like peptide-1 receptor and inhibition of cannabinoid CB1 receptor act synergistically to reduce food intake and body weight in the rat

Risks of Rapid Dose Escalation Speeding up dose escalation may seem beneficial at first, especially when patients experience quick weight loss or improved glucose control with GLP-1 therapy

No single dietary approach proves universally superior

However, observational studies are open to residual confounding, such as by socioeconomic position and health status, and cannot distinguish whether l-carnitine is a biomarker or a causal factor, making them difficult to use as a guide to interventions [17]

Importance of P-glycoprotein at bloodtissue barriers

Khoronenkova SV, Dianova II, Ternette N, Kessler BM, Parsons JL, Dianov GL